GlassScriptPhysician profile
John Michael Nowins
NPI 1912047176
$836.20
in general payments reported to CMS, 2019-2025
11 companies · $31.46 in 2025
The $31.46 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.34 · 2020: $85.62 · 2021: $51.66 · 2022: $243 · 2023: $168 · 2024: $196 · 2025: $31.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $565.53 | 2019-2025 | Rybelsus, Ozempic, Tresiba |
| Abbvie INC. | $52.99 | 2021-2022 | |
| Myovant Sciences INC. | $43.73 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $34.35 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $32.09 | 2019-2020 | |
| Amgen INC. | $30.60 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $26.58 | 2023 | Seglentis |
| Sumitomo Pharma America, INC. | $13.72 | 2023 | Myfembree |
| Organon LLC | $12.67 | 2024 | |
| Lupin INC. | $12.46 | 2020 | |
| Therapeuticsmd, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nowins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.